Factor XIII-mediated inhibition of fibrinolysis and venous leg ulcers.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  The Lancet

• Publication date

  2000-06-03

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0140-6736(00)02333-3PMID 10859047
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of Factor XIII on Endothelial Barrier Function

  1999cited by this paper
• Lipodermatosclerosis is characterized by elevated expression and activation of matrix metalloproteinases: implications for venous ulcer formation.

  1998cited by this paper
• Control of type IV collagenase activity by components of the urokinase–plasmin system: a regulatory mechanism with cell‐bound reactants

  1997cited by this paper
• Tissue and urokinase plasminogen activators in the environs of venous and ischaemic leg ulcers

  1993cited by this paper
• The cause of venous ulceration.

  1982cited by this paper

• Vascular leakage and angiogenesis in wound healing: a review

  2025cites this paper
• The impact of acquired coagulation factor XIII deficiency in traumatic bleeding and wound healing

  2022cites this paper
• Dynamics of coagulation factor XIII activity after video-assisted thoracoscopic lobectomy for non-small cell lung cancer.

  2019cites this paper
• Effect of early administration of coagulation factor XIII on fistula after pancreatic surgery: the FIPS randomized controlled trial

  2018cites this paper
• Factor XIII Subunit A in the Skin: Applications in Diagnosis and Treatment

  2017cites this paper
• Coagulation Factor XIIIA (F13A1): Novel Perspectives in Treatment and Pharmacogenetics.

  2016cites this paper
• Coagulation factor XIII: a multifunctional transglutaminase with clinical potential in a range of conditions

  2015cites this paper
• The response of skin hardness and pain sensation to ultrasonic treatment in lipodermatosclerosis patients

  2014cites this paper
• Tissue‐regenerating functions of coagulation factor XIII

  2013cites this paper
• Association of C46T genetic polymorphism of coagulation factor XII with deep venous thrombosis: a cohort study on Egyptian patients

  2013cites this paper
• Factor XIII: a coagulation factor with multiple plasmatic and cellular functions.

  2011cites this paper
• Australia and New Zealand clinical practice guideline for prevention and management of venous leg ulcers

  2011cites this paper
• Venous Leg Ulcer in a 42-Year-Old Woman: What Should We Think About?

  2009cites this paper
• Mechanismen der Wundheilung

  2009cites this paper
• Treatment of recalcitrant venous leg ulcers with autologous keratinocytes in fibrin sealant: A multinational randomized controlled clinical trial

  2007cites this paper
• [Chronic wounds. Novel approaches in research and therapy].

  2007cites this paper
• Factor XIIIA-V 34 L and Factor XIIIB-H 95 R Gene Variants : Effects on Survival in Myocardial Infarction Patients

  2007cites this paper
• Clinical implications of gene polymorphisms in venous leg ulcer: A model in tissue injury and reparative process

  2007cites this paper
• Factor XIIIA-V34L and Factor XIIIB-H95R Gene Variants: Effects on Survival in Myocardial Infarction Patients

  2007cites this paper
• Evidence for placebo effects on physical but not on biochemical outcome parameters: a review of clinical trials

  2007cites this paper
• Factor XIII therapy of anastomotic leak, and circulating growth factors.

  2006cites this paper
• Soluble CD40 ligand in prediction of acute severe pancreatitis.

  2006cites this paper
• Prognostic role of factor XIII gene variants in nonhealing venous leg ulcers.

  2006cites this paper
• Mechanismen zur Beeinflussung der Zellphysiologie als Wundheilungskonzept

  2005cites this paper
• [Mechanisms influencing cellular physiology as a concept of treatment for wound healing disturbances].

  2005cites this paper
• Gene transfer of keratinocytes with a human Factor XIII-plasmid construct INAUGURAL –

  2005cites this paper
• Factor XIII V34L polymorphism modulates the risk of chronic venous leg ulcer progression and extension

  2004cites this paper
• Factor XIII Contrasts the Effects of Metalloproteinases in Human Dermal Fibroblast Cultured Cells

  2004cites this paper
• Venous leg ulcers and apoptosis: a TIMP-3-mediated pathway?

  2004cites this paper
• Effectiveness of Coagulation Factor XIII Concentrate for Reversing Loss of Tensile Strength of Rat Intestinal Anastomoses

  2004cites this paper
• Severity of venous insufficiency is related to the density of microvascular deposition of PAI-1, uPA and von Willebrand factor.

  2004cites this paper
• Recombinant biologics for treatment of bleeding disorders

  2004cites this paper
• Polymorphisms in coagulation factor genes and their impact on arterial and venous thrombosis.

  2003cites this paper
• Treatment of nonhealing leg ulcers with fibrin-stabilizing factor XIII: a case report.

  2002cites this paper
• Elevated expression of extracellular matrix metalloproteinase inducer (CD147) and membrane‐type matrix metalloproteinases in venous leg ulcers

  2002cites this paper
• Efeito do fator XIII da coagulação na cicatrização da pele de ratos em uso de corticosteróide

  2002cites this paper
• The role of the urokinase‐type plasminogen activator (uPA) and its receptor (CD87) in lipodermatosclerosis

  2001cites this paper
• Factor XIII replacement in stem cell transplant (SCT) recipients with severe graft-versus-host disease of the bowel: report of an initial experience.

  2001cites this paper
• Inflammation in stasis dermatitis upregulates MMP-1, MMP-2 and MMP-13 expression.

  2001cites this paper
• Cutaneous Wound Healing: An Update

  2001cites this paper